Variation in folate pathway genes and distal colorectal adenoma risk: A sigmoidoscopy-based case-control study

Cancer Causes and Control

Volumn 22, Issue 4, 2011, Pages 541-552

  Levine, A Joan ^a   Lee, Won ^a   Figueiredo, Jane C ^a   Conti, David V ^a   Vandenberg, David J ^a   Davis, Brian D ^a   Edlund, Christopher K ^a   Henning, Susanne M ^b   Heber, David ^b   Stern, Mariana C ^a   Haile, Robert W ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Colorectal adenoma; Folate; MTHFR; SLC19A1; TagSNP

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; DIHYDROFOLATE REDUCTASE; FOLATE RECEPTOR; FOLIC ACID; GLYCINE HYDROXYMETHYLTRANSFERASE; HOMOCYSTEINE; INTRINSIC FACTOR; METHIONINE ADENOSYLTRANSFERASE; METHIONINE SYNTHASE; METHYLENETETRAHYDROFOLATE DEHYDROGENASE; REDUCED FOLATE CARRIER; THYMIDYLATE SYNTHASE;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; CBS GENE; COLORECTAL ADENOMA; CONTROLLED STUDY; DFHR GENE; DIETARY INTAKE; FEMALE; FOLR1 GENE; GENE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GIF GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MAT2A GENE; MTHFD1 GENE; MTHFR GENE; MTR GENE; NEGRO; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SHMT GENE; SIGMOIDOSCOPY; SINGLE NUCLEOTIDE POLYMORPHISM; SLC19A1 GENE; TYMS GENE;

ADENOMA; AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MODELS, BIOLOGICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; REDUCED FOLATE CARRIER PROTEIN; RISK FACTORS; SIGMOIDOSCOPY;

EID: 79955777647     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-011-9726-7     Document Type: Article

References (54)

1. Kim YI (2003) Role of folate in colon cancer development and progression. J Nutr 133:3731S-3739S
2. Giovannucci E (2002) Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr 132:2350S-2355S (Pubitemid 34848106)
3. Mason JB, Choi SW (2000) The mechanisms by which folate depletion enhances colorectal carcinogenesis: a unified scheme. Nestle Nutr Workshop Ser Clin Perform Programme 4:87-99; discussion 99-101
4. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, McKeown-Eyssen G, Summers RW, Rothstein RI, Burke CA et al (2007) Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 297:2351-2359 (Pubitemid 46883748)
5. Song J, Medline A, Mason JB, Gallinger S, Kim YI (2000) Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse. Cancer Res 60:5434-5440
6. Song J, Sohn KJ, Medline A, Ash C, Gallinger S, Kim YI (2000) Chemopreventive effects of dietary folate on intestinal polyps in Apc ± Msh2-/- mice. Cancer Res 60:3191-3199 (Pubitemid 30407916)
7. Nijhout HF, Reed MC, Ulrich CM (2008) Mathematical models of folate-mediated one-carbon metabolism. Vitam Horm 79: 45-82
8. Ulrich CM, Neuhouser M, Liu AY, Boynton A, Gregory JF III, Shane B, James SJ, Reed MC, Nijhout HF (2008) Mathematical modeling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to car-cinogenesis. Cancer Epidemiol Biomarkers Prev 17:1822-1831
9. Ulrich CM (2005) Nutrigenetics in cancer research-folate metabolism and colorectal cancer. J Nutr 135:2698-2702 (Pubitemid 43156616)
10. Xu X, Liu AY, Ulrich CM, Chen J (2009) Folate and cancer: epidemiological perspective. Taylor and Francis, New York
11. Huang Y, Han S, Li Y, Mao Y, Xie Y (2007) Different roles of MTHFR C677T and A1298C polymorphisms in colorectal adenoma and colorectal cancer: a meta-analysis. J Hum Genet 52:73-85 (Pubitemid 46020567)
12. Kono S, Chen K (2005) Genetic polymorphisms of methylene- tetrahydrofolate reductase and colorectal cancer and adenoma. Cancer Sci 96:535-542 (Pubitemid 41488416)
13. Hazra A, Wu K, Kraft P, Fuchs CS, Giovannucci EL, Hunter DJ (2007) Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study. Carcinogenesis 28:1510-1519 (Pubitemid 47243540)
14. Stern MC, Siegmund KD, Conti DV, Corral R, Haile RW (2006) XRCC1, XRCC3, and XPD polymorphisms as modifiers of the effect of smoking and alcohol on colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 15:2384-2390 (Pubitemid 46048294)
15. Stern MC, Siegmund KD, Corral R, Haile RW (2005) XRCC1 and XRCC3 polymorphisms and their role as effect modifiers of unsaturated fatty acids and antioxidant intake on colorectal adenomas risk. Cancer Epidemiol Biomarkers Prev 14:609-615 (Pubitemid 40489203)
16. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC (1992) Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol 135:1114-1126; discussion 1127-1136
17. Stram DO, Hankin JH, Wilkens LR, Pike MC, Monroe KR, Park S, Henderson BE, Nomura AM, Earle ME, Nagamine FS et al (2000) Calibration of the dietary questionnaire for a multiethnic cohort in Hawaii and Los Angeles. Am J Epidemiol 151:358-370 (Pubitemid 30463613)
18. Bird CL, Swendseid ME, Witte JS, Shikany JM, Hunt IF, Frankl HD, Lee ER, Longnecker MP, Haile RW (1995) Red cell and plasma folate, folate consumption, and the risk of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 4:709-714
19. Kuo K, Still R, Cale S, McDowell I (1997) Standardization (external and internal) of HPLC assay for plasma homocysteine. Clin Chem 43:1653-1655 (Pubitemid 27396361)
20. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265 (Pubitemid 40202029)
21. Shen R, Fan JB, Campbell D, Chang W, Chen J, Doucet D, Yeakley J, Bibikova M, Wickham Garcia E, McBride C et al (2005) High-throughput SNP genotyping on universal bead arrays. Mutat Res 573:70-82 (Pubitemid 40514402)
22. Consortium TIH (2005) A haplotype map of the human genome. Nature 437:1299-1320
23. Levine AJ, Siegmund KD, Ervin CM, Diep A, Lee ER, Frankl HD, Haile RW (2000) The methylenetetrahydrofolate reductase 677C→T polymorphism and distal colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 9:657-663 (Pubitemid 30482695)
24. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113
25. Li Y, Abecasis GR (2006) Mach 1.0: rapid haplotype reconstruction and missing genotype inference. Am J Hum Genet S79:2290
26. Conneely KN, Boehnke M (2007) So many correlated tests, so little time! Rapid adjustment of p values for multiple correlated tests. Am J Hum Genet 81:1158-1168 (Pubitemid 350211447)
27. Lucock M (2000) Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol Genet Metab 71:121-138
28. Ma DW, Finnell RH, Davidson LA, Callaway ES, Spiegelstein O, Piedrahita JA, Salbaum JM, Kappen C, Weeks BR, James J et al (2005) Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res 65:887-897 (Pubitemid 40216448)
29. Eklof V, Van Guelpen B, Hultdin J, Johansson I, Hallmans G, Palmqvist R (2008) The reduced folate carrier (RFC1) 80G>A and folate hydrolase 1 (FOLH1) 1561C>T polymorphisms and the risk of colorectal cancer: a nested case-referent study. Scand J Clin Lab Invest 68:393-401
30. Ulrich CM, Curtin K, Potter JD, Bigler J, Caan B, Slattery ML (2005) Polymorphisms in the reduced folate carrier, thymidylate synthase, or methionine synthase and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 14:2509-2516 (Pubitemid 41752708)
31. Boyapati SM, Bostick RM, McGlynn KA, Fina MF, Roufail WM, Geisinger KR, Hebert JR, Coker A, Wargovich M (2004) Folate intake, MTHFR C677T polymorphism, alcohol consumption, and risk for sporadic colorectal adenoma (United States). Cancer Causes Control 15:493-501 (Pubitemid 39060941)
32. Marugame T, Tsuji E, Kiyohara C, Eguchi H, Oda T, Shinchi K, Kono S (2003) Relation of plasma folate and methylenetetrahy- drofolate reductase C677T polymorphism to colorectal adenomas. Int J Epidemiol 32:64-66 (Pubitemid 36503476)
33. Ulrich CM, Kampman E, Bigler J, Schwartz SM, Chen C, Bostick R, Fosdick L, Beresford SA, Yasui Y, Potter JD (1999) Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev 8:659-668 (Pubitemid 30064533)
34. Ulvik A, Evensen ET, Lien EA, Hoff G, Vollset SE, Majak BM, Ueland PM (2001) Smoking, folate and methylenetetrahy- drofolate reductase status as interactive determinants of ade- nomatous and hyperplastic polyps of colorectum. Am J Med Genet 101:246-254 (Pubitemid 32565701)
35. Chen J, Giovannucci E, Hankinson SE, Ma J, Willett WC, Spiegelman D, Kelsey KT, Hunter DJ (1998) A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma. Carcinogenesis 19:2129-2132 (Pubitemid 29010251)
36. Giovannucci E, Chen J, Smith-Warner SA, Rimm EB, Fuchs CS, Palomeque C, Willett WC, Hunter DJ (2003) Methylenetetrahy-drofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 12:970-979 (Pubitemid 37310251)
37. Lightfoot TJ, Barrett JH, Bishop T, Northwood EL, Smith G, Wilkie MJ, Steele RJ, Carey FA, Key TJ, Wolf R et al (2008) Methylene tetrahydrofolate reductase genotype modifies the chemopreventive effect of folate in colorectal adenoma, but not colorectal cancer. Cancer Epidemiol Biomarkers Prev 17:2421-2430
38. van den Donk M, Buijsse B, van den Berg SW, Ocke MC, Harryvan JL, Nagengast FM, Kok FJ, Kampman E (2005) Dietary intake of folate and riboflavin, MTHFR C677T genotype, and colorectal adenoma risk: a Dutch case-control study. Cancer Epidemiol Biomarkers Prev 14:1562-1566 (Pubitemid 40807363)
39. Mitrou PN, Watson MA, Loktionov AS, Cardwell C, Gunter MJ, Atkin WS, Macklin CP, Cecil T, Bishop TD, Primrose J et al (2006) MTHFR (C677T and A1298C) polymorphisms and risk of sporadic distal colorectal adenoma in the UK flexible sigmoid- oscopy screening trial (United Kingdom). Cancer Causes Control 17:793-801
40. Curtin K, Bigler J, Slattery ML, Caan B, Potter JD, Ulrich CM (2004) MTHFR C677T and A1298C polymorphisms: diet, estrogen, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 13:285-292 (Pubitemid 38222562)
41. Keku T, Millikan R, Worley K, Winkel S, Eaton A, Biscocho L, Martin C, Sandler R (2002) 5,10-Methylenetetrahydrofolate reductase codon 677 and 1298 polymorphisms and colon cancer in African Americans and whites. Cancer Epidemiol Biomarkers Prev 11:1611-1621 (Pubitemid 36020015)
42. Matsuo K, Ito H, Wakai K, Hirose K, Saito T, Suzuki T, Kato T, Hirai T, Kanemitsu Y, Hamajima H et al (2005) One-carbon metabolism related gene polymorphisms interact with alcohol drinking to influence the risk of colorectal cancer in Japan. Carcinogenesis 26:2164-2171 (Pubitemid 41672204)
43. Otani T, Iwasaki M, Hanaoka T, Kobayashi M, Ishihara J, Natsukawa S, Shaura K, Koizumi Y, Kasuga Y, Yoshimura K et al (2005) Folate, vitamin B6, vitamin B12, and vitamin B2 intake, genetic polymorphisms of related enzymes, and risk of colorectal cancer in a hospital-based case-control study in Japan. Nutr Cancer 53:42-50 (Pubitemid 43068552)
44. Koushik A, Kraft P, Fuchs CS, Hankinson SE, Willett WC, Giovannucci EL, Hunter DJ (2006) Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer. Cancer Epidemiol Biomarkers Prev 15:2408-2417 (Pubitemid 46048297)
45. Curtin K, Slattery ML, Ulrich CM, Bigler J, Levin TR, Wolff RK, Albertsen H, Potter JD, Samowitz WS (2007) Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet. Carcinogenesis 28:1672-1679 (Pubitemid 47303944)
46. Yin G, Kono S, Toyomura K, Hagiwara T, Nagano J, Mizoue T, Mibu R, Tanaka M, Kakeji Y, Maehara Y et al (2004) Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka colorectal cancer study. Cancer Sci 95:908-913 (Pubitemid 40045526)
47. Murtaugh MA, Curtin K, Sweeney C, Wolff RK, Holubkov R, Caan BJ, Slattery ML (2007) Dietary intake of folate and co-factors in folate metabolism, MTHFR polymorphisms, and reduced rectal cancer. Cancer Causes Control 18:153-163 (Pubitemid 46215312)
48. Chango A, Emery-Fillon N, de Courcy GP, Lambert D, Pfister M, Rosenblatt DS, Nicolas JP (2000) A polymorphism (80G→A) in the reduced folate carrier gene and its associations with folate status and homocysteinemia. Mol Genet Metab 70:310-315
49. Devlin AM, Clarke R, Birks J, Evans JG, Halsted CH (2006) Interactions among polymorphisms in folate-metabolizing genes and serum total homocysteine concentrations in a healthy elderly population. Am J Clin Nutr 83:708-713 (Pubitemid 44699220)
50. Feix A, Fritsche-Polanz R, Kletzmayr J, Vychytil A, Horl WH, Sunder-Plassmann G, Fodinger M (2001) Increased prevalence of combined MTR and MTHFR genotypes among individuals with severely elevated total homocysteine plasma levels. Am J Kidney Dis 38:956-964 (Pubitemid 33022172)
51. Gross M, Friedman G, Eliashar R, Koren-Morag N, Goldschmidt N, Atta IA, Ben-Yehuda A (2006) Impact of methionine synthase gene and methylenetetrahydrofolate reductase gene polymorphisms on the risk of sudden sensorineural hearing loss. Audiol Neurootol 11:287-293 (Pubitemid 44496282)
52. Le Marchand L, Donlon T, Hankin JH, Kolonel LN, Wilkens LR, Seifried A (2002) B-vitamin intake, metabolic genes, and colo- rectal cancer risk (United States). Cancer Causes Control 13:239-248
53. Mostowska A, Hozyasz KK, Wojcicki P, Dziegelewska M, Jagodzinski PP (2009) Associations of folate and choline metabolism gene polymorphisms with orofacial clefts. J Med Genet 47:809-815
54. Terruzzi I, Senesi P, Fermo I, Lattuada G, Luzi L (2007) Are genetic variants of the methyl group metabolism enzymes risk factors predisposing to obesity? J Endocrinol Invest 30:747-753 (Pubitemid 350238200)